診療技術部看護部各委員会報告業績編集後記教育講演会・研修会・研究会天神会医療研究会抄録５．Shimada A, Kawasaki E, Abiru N, et al. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version). Diabetol Int 16 (1): 1-6, 2024 ６．Ebisuno T, Tachibana M, Kawasaki E, et al. Analysis of thyroid autoantibodies and the risk of insulin depletion after the clinical onset of acute-onset type 1 diabetes in Japanese patients: the TIDE-J study. Diabetol Int 16 (1): 39-49, 2024７．Ebisuno T, Tachibana M, Kawasaki E, et al. Analysis of thyroid autoantibodies and the risk of insulin depletion after the clinical onset of acute-onset type 1 diabetes in Japanese patients: the TIDE-J study. Diabetol Int 16 (1): 39-49, 2024８．Kawasaki E, Takahashi Y, Komeda T, et al. Evaluation of biochemical characteristics and performance of the 3 Screen ICA ELISA kit Int J Mol Sci 25(22):12182, 2024 ９．Shimada A, Kawasaki E, Abiru N, et al. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version). J Diabetes Incestig 16 (1): 163-168, 202510．川﨑英二 臨床検査値の評価 病態栄養専門管理栄養士のための病態栄養ガイドブック改訂第 8 版：89 － 94、202511．Hiromatsu Y, Ishikawa E, Kozaki A, et al. A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients. Lancet Reg Health West Pac. 2025 Jan 18;55:101464. doi: 10.1016/j.lanwpc.2025.101464. eCollection 2025 Feb. PMID: 3989623012．Mizuochi K, Hiromatsu Y, Nakamura Y, et al. Transition from hypothyroidism to Graves' disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature. Endocr J. 2025 Jan 6;72(1):115-122. doi: 10.1507/endocrj.EJ24-0347. Epub 2024 Sep 25.PMID: 39322555 13．Kawasaki E, Tamai H, Hiromatsu Y, et al. Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease. World J Diabetes. 2024 May 15;15(5):935-944. doi: 10.4239/wjd.v15.i5.935. PMID: 38766435— 194 —
元のページ ../index.html#201